SUBSEQUENT EVENT	3 Months Ended
Mar. 31, 2026
Subsequent Events [Abstract]
SUBSEQUENT EVENT	NOTE 23 - SUBSEQUENT EVENT Subsequent Event Private Placement On June 25, 2026, Company received a written notice from Nasdaq (the “Extension Letter”) stating that it had accepted the Company’s plan to regain compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”). Nasdaq granted the Company a plan period to regain compliance with the Rule. (I) As previously reported in the current report on Forms 8- K (the “Previous Announcements”) filed on April 27, 2026 and May 29, 2026 with the Securities Exchange Commission by the Company, the Company announced that it received delinquency notifications from Nasdaq on April 23, 2026 and May 26, 2026 (the “Deficiency Letters”), due to the Company’s non-compliance with the Rule as a result of the Company’s failure to timely file its annual report on Form 10-K for the period ended December 31, 2025 (the “2025 Form 10-K”) and its quarterly report on Form 10-Q for the period ended March 31, 2026 (the “2026 Q1 Form 10-Q” and together with the “2025 Form 10- K”, the “Delinquent Reports”), respectively. (II) The Company submitted a plan to the Nasdaq Listing Qualification (the “Staff”) to regain compliance (the “Compliance Plan”) with the Nasdaq Requirements on June 17, 2026. Under the Extension Letter, the Company is required to file its delinquent 2025 Form 10-K and 2026 Q1 Form 10-Q by the applicable extended deadline to evidence compliance with the relevant Nasdaq requirements.The Extension Letter further provides that if the Company fails to evidence compliance upon filing the Delinquent Reports, Staff will notify the Company that its securities will be subject to delisting. (III)The previously received Deficiency Letters and the Extension Letter have no immediate effect on the listing or trading of the Company’s common stock on Nasdaq, subject to the Company’s continued compliance with the other applicable listing requirements. (IV)The Company subsequently filed the 2025 Form 10-K on August 17, 2026 with the Securities and Exchange Commission. On April 8,2026, the company issued 70,000 shares of its common stock to one individual investor at an agreed price of $3.94 per share for aggregate proceeds of $275,800, pursuant to the private placement agreement dated on March 19, 2026. On April 14,2026, the company issued 60,000 shares of its common stock to one individual investor at an agreed price of $4.1 per share for aggregate proceeds of $246,000, pursuant to the private placement agreement dated on March 28, 2026.

SUBSEQUENT EVENT

3 Months Ended

Mar. 31, 2026

NOTE 23 - SUBSEQUENT EVENT

Subsequent Event

On June 25, 2026, Company received a written notice from Nasdaq (the “Extension Letter”) stating that it had accepted the Company’s plan to regain compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”). Nasdaq granted the Company a plan period to regain compliance with the Rule. (I) As previously reported in the current report on Forms 8- K (the “Previous Announcements”) filed on April 27, 2026 and May 29, 2026 with the Securities Exchange Commission by the Company, the Company announced that it received delinquency notifications from Nasdaq on April 23, 2026 and May 26, 2026 (the “Deficiency Letters”), due to the Company’s non-compliance with the Rule as a result of the Company’s failure to timely file its annual report on Form 10-K for the period ended December 31, 2025 (the “2025 Form 10-K”) and its quarterly report on Form 10-Q for the period ended March 31, 2026 (the “2026 Q1 Form 10-Q” and together with the “2025 Form 10- K”, the “Delinquent Reports”), respectively. (II) The Company submitted a plan to the Nasdaq Listing Qualification (the “Staff”) to regain compliance (the “Compliance Plan”) with the Nasdaq Requirements on June 17, 2026. Under the Extension Letter, the Company is required to file its delinquent 2025 Form 10-K and 2026 Q1 Form 10-Q by the applicable extended deadline to evidence compliance with the relevant Nasdaq requirements.The Extension Letter further provides that if the Company fails to evidence compliance upon filing the Delinquent Reports, Staff will notify the Company that its securities will be subject to delisting. (III)The previously received Deficiency Letters and the Extension Letter have no immediate effect on the listing or trading of the Company’s common stock on Nasdaq, subject to the Company’s continued compliance with the other applicable listing requirements. (IV)The Company subsequently filed the 2025 Form 10-K on August 17, 2026 with the Securities and Exchange Commission.

On April 8,2026, the company issued 70,000 shares of its common stock to one individual investor at an agreed price of $3.94 per share for aggregate proceeds of $275,800, pursuant to the private placement agreement dated on March 19, 2026.

On April 14,2026, the company issued 60,000 shares of its common stock to one individual investor at an agreed price of $4.1 per share for aggregate proceeds of $246,000, pursuant to the private placement agreement dated on March 28, 2026.